KV Pharmaceutical, Purdue Pharma settle painkiller patent dispute - South Florida Business Journal:

olimstgon.blogspot.com
Under the settlement, KV agreecd to no longer dispute the enforceabilityor infringement” of the Purdue generic oxycodonde patents. In return, Purdue granted KV a limited, non-exclusive license to manufactureand sell, in the United a certain amount of various dosager strengths of the drugs as long as KV pays royaltie to Purdue. KV also reached a deal to be an non-exclusive distributor in the United Statesd of certain generic versionsof OxyContin. These agreementse settle three patent infringementlawsuits Stamford, Conn.-based Purdus filed against KV in 2007. KV still faces more lawsuitsa fromother companies, consumers and shareholders. Threed individuals in St.
Clair County Circuit Court againstf KV, alleging that certain drugs contained a potentially lethalk amount of morphine due to oversized tabletxs that were eventually recalled by the pharmaceutical Last month, , a Florida-base dermatology company, sued KV, of a patent for Duac topical gel, an acne medication. KV also facew lawsuits from shareholders about manufacturing compliance andthe company’se financial prospects. Brentwood, Mo.-based KV has and recalled In March, KV said it with the FDA that outlines a series of measures that will permit KV and its subsidiariex to resume manufacturingand distribution.